U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07033013) titled 'A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).' on June 13.

Brief Summary: Randomized, Double-Blind, Placebo-Controlled, Single-Center Clinical Study with a Run-in Baseline, Daily Diary Log, and Validated Questionnaires (Greene GCS) with Oral Dietary Supplement

Study Start Date: June 20

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DIETARY_SUPPLEMENT: Placebo

Placebo

DIETARY_SUPPLEMENT: Dietary Supplement with actives

Dietary supplement containing EstroG-100 and GABA

Recruitment...